Deka不同之处
MONALISA TOUCH®: THE REVOLUTIONARY NON-SURGICAL APPROACH TO GYNAECOLOGICAL HEALTHMonaLisa Touch® is the best-known and most widespread laser procedure designed to treat vulvovaginal conditions. Issues related to gynaecological health are commonly seen in millions of postmenopausal women, breast cancer survivors and hysterectomized women. MonaLisa Touch® provides a unique solution for all women experiencing post‐menopausal symptoms, without any of the adverse side effects caused by drug-based therapies.
我们是激光技术领域的卓越者
SmartXide2 CO2 激光器：无与伦比的多功能性
SmartXide2, with V2LR configuration, offers the latest breakthrough laser treatment for the MonaLisa Touch® procedure and cosmetic/functional female genital surgery. To perform these innovative procedures, DEKA has designed a new radiofrequency CO2 laser, featuring proprietary PSD® (Pulse Shape Design) technology. This generates the only pulse specifically developed for treating genital mucosa: D-Pulse or DEKAPulse.Why choose MonaLisa Touch®:
• Effective. The sole procedure demonstrated by clinical, histological and ultrastructural studies published in the international peer-reviewed literature.
• Simple. In-office non-surgical procedure, 5-minute treatments; the ergonomic scanner and probes make it easy to perform.
• Safe. Virtually side effect-free. Minimally invasive. Thousands of women successfully treated since 2009.
• Painless. Requiring no anaesthesia inside the vagina. Very short downtime.
• Immediate. Symptom relief after just 1 treatment, even greater improvement after treatments 2 and 3.
• Non-hormonal therapy. Suitable for patients who cannot, or prefer not to receive oestrogen therapy.
• Cheaper than alternatives involving tablets or creams that need to be taken/applied every day for months and that only focus on symptoms rather than address the causes.
临床案例
• MonaLisa Touch
• Surgical V²LR
• Surgical V²LR
“MonaLisa Touch® is certainly the procedure that has the best evidence in medical literature, showing how safe and how good it is. Other lasers still have to produce that evidence and each single laser is completely different from the other, so we cannot actually say that all CO2 lasers produce the same effects with the same safety.”
Stefano Salvatore, MD
Head of the Urogynaecology Unit, IRCCS San Raffaele Hospital, Milan – Italy.
“My studies demonstrated that the uniquely delivered DEKA CO2 laser is capable of treating lichen sclerosus effectively. MonaLisa Touch® procedure represents a significant divergence from steroid- and corticosteroid-bulwark dependence and their expected serious side effects.”
Michael S. Baggish, MD, FACS, FACOG
St. Helena Hospital, St. Helena - CA (USA), Dept. of Obstetrics and Gynecology, University of California, San Francisco - CA (USA)
Stefano Salvatore, MD
Head of the Urogynaecology Unit, IRCCS San Raffaele Hospital, Milan – Italy.
“My studies demonstrated that the uniquely delivered DEKA CO2 laser is capable of treating lichen sclerosus effectively. MonaLisa Touch® procedure represents a significant divergence from steroid- and corticosteroid-bulwark dependence and their expected serious side effects.”
Michael S. Baggish, MD, FACS, FACOG
St. Helena Hospital, St. Helena - CA (USA), Dept. of Obstetrics and Gynecology, University of California, San Francisco - CA (USA)
